Related Experiment Videos
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
Antimicrobial Agents and Chemotherapy
|October 1, 1986
Summary
Laboratory-induced methicillin resistance in Staphylococcus aureus involves changes in penicillin-binding proteins (PBPs). A novel PBP 2a, similar to that in resistant strains, emerged, suggesting PBP 2a evolved from PBP 2.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Methicillin resistance in Staphylococcus aureus (S. aureus) is a significant clinical challenge.
- Understanding the origin of this resistance is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the laboratory-induced origin of methicillin resistance in S. aureus.
- To characterize the alterations in penicillin-binding proteins (PBPs) associated with increasing resistance levels.
Main Methods:
- Isolation of S. aureus mutants with increasing resistance to beta-lactam antibiotics through laboratory selection.
- Analysis of penicillin-binding protein alterations using penicillin binding assays and partial proteolysis.
- Comparison of PBPs from susceptible and resistant strains.
Main Results:
- Low- and intermediate-level resistance showed specificity for the selecting antibiotic and altered PBP binding.
- High-level methicillin resistance was associated with the loss of PBPs 2 and 3 and the appearance of a new 78 kDa PBP (PBP 2a).
- PBP 2a shares some peptide fragments with PBP 2, suggesting an evolutionary link.
Conclusions:
- Laboratory-induced methicillin resistance in S. aureus involves the emergence of PBP 2a, analogous to clinical isolates.
- PBP 2a likely evolved from PBP 2 through mutational changes affecting the beta-lactam binding site.
- Resistance mechanisms in S. aureus are linked to specific PBP modifications.